Working… Menu

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. (MEDI8897 Ph2b)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02878330
Recruitment Status : Completed
First Posted : August 25, 2016
Last Update Posted : December 20, 2018
Information provided by (Responsible Party):
MedImmune LLC

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : July 17, 2018
Actual Study Completion Date : December 6, 2018
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 July 17, 2019
August 6, 2019
2 August 19, 2019
September 9, 2019
3 September 24, 2019